Allovir, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
ALVR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1100 Winter Street, Waltham, Massachusetts

Insiders trading volume in the past year

Allovir, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Morana Jovan-Embiricos Director, 10%+ Owner $21.1 M Jun 6, 2024
David Hallal Director, 10%+ Owner $15.6 M Jun 6, 2024
Vikas Sinha Officer Title: President and Chief Financial Officer, Director, 10%+ Owner $12.8 M -$72.3 K -0.56% Jul 2, 2024
Ansbert Gadicke Director, 10%+ Owner $11.2 M Jul 28, 2022
ElevateBio, LLC Director, 10%+ Owner $11.2 M Jul 28, 2022
Gilead Sciences, Inc. 10%+ Owner $11.2 M Jun 27, 2023
F2 MG Ltd Director, 10%+ Owner $6.59 M Jul 28, 2022
John Robert Wilson Director $2.12 M May 25, 2021
Juan Vera Director $1.91 M Jun 6, 2024
Diana Brainard Chief Executive Officer, Director $564 K -$162 K -22.4% Jul 2, 2024
Edward Miller General Counsel $366 K -$11.1 K -2.94% Jul 2, 2024
Agustin Melian Chief Medical Officer $304 K Oct 4, 2021
Jeroen B. Van Beek Chief Commercial Officer $224 K Nov 16, 2022
Malcolm Brenner Director $209 K Jun 6, 2024
Cintia Piccina Chief Commercial Officer $98.6 K Jul 3, 2023
Ercem Atillasoy Officer $88.1 K Oct 20, 2022
Jeffrey S. Bornstein Director $87.3 K Jun 6, 2024
Ann M. Leen Chief Scientific Officer $83.2 K Aug 16, 2022
Shawn Tomasello Director $55.5 K Jun 6, 2024
Derek N. Adams Director $55.5 K Jun 6, 2024
Brett Hagen Chief Accounting Officer $54.1 K -$44.9 K -45.3% Jul 2, 2024

Recent Insider Transactions by Companies or Individuals for Allovir, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership